RhumbLine Advisers’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-147,167
| Closed | -$982K | – | 4287 |
|
|
2023
Q3 | $982K | Buy |
147,167
+2,101
| +1% | +$14K | ﹤0.01% | 2223 |
|
|
2023
Q2 | $1.31M | Buy |
145,066
+31,742
| +28% | +$288K | ﹤0.01% | 2152 |
|
|
2023
Q1 | $824K | Buy |
113,324
+12,344
| +12% | +$89.8K | ﹤0.01% | 2216 |
|
|
2022
Q4 | $736K | Buy |
100,980
+8,122
| +9% | +$59.2K | ﹤0.01% | 2288 |
|
|
2022
Q3 | $718K | Buy |
92,858
+6,580
| +8% | +$50.9K | ﹤0.01% | 2326 |
|
|
2022
Q2 | $588K | Buy |
+86,278
| New | +$588K | ﹤0.01% | 2406 |
|